Clinical trial IMBrella
An open label, multicenter extension study in patients previously enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd sponsored atezolizumab study (IMBRELLA B)
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 4 |
| Academic trial | Non |
| Sponsor | Roche |
| EudraCT Identifier | 2018-003352-20 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03768063 |
| Inclusion criteria | Participated in parent study |
| Last update |